The Copenhagen Insulin and Metformin Therapy Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

415

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Type 2 DiabetesAtherosclerosisArteriosclerosis
Interventions
DRUG

metformin

metformin tablets 2 g x 2

DRUG

insulin detemir

insulin as requested

DRUG

insulin aspart + insulin aspart protamin

insulin as requested

DRUG

Insulin aspart

insulin as requested

Trial Locations (9)

2000

Frederiksberg Hospital, Frederiksberg

2100

Rigshospitalet, Copenhagen

2400

Bispebjerg Hospital, Copenhagen

2650

Hvidovre Hospital, Hvidovre

2820

Gentofte Sygehus, Gentofte Municipality

Steno Diabetes Center, Gentofte Municipality

2830

Herlev Hospital, Herlev

3400

Hillerod Sygehus, Hillerød

4600

Køge Sygehus, Køge

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Hvidovre University Hospital

OTHER

collaborator

Hillerod Hospital, Denmark

OTHER

collaborator

Frederiksberg University Hospital

OTHER

collaborator

University Hospital, Gentofte, Copenhagen

OTHER

collaborator

Rigshospitalet, Denmark

OTHER

collaborator

Bispebjerg Hospital

OTHER

collaborator

Herlev Hospital

OTHER

collaborator

Zealand University Hospital

OTHER

collaborator

Copenhagen Trial Unit, Center for Clinical Intervention Research

OTHER

collaborator

Novo Nordisk A/S

INDUSTRY

lead

Steno Diabetes Center Copenhagen

OTHER

NCT00657943 - The Copenhagen Insulin and Metformin Therapy Trial | Biotech Hunter | Biotech Hunter